|
[Related PubMed/MEDLINE] Total Number of Papers: 21
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: mpMRI |
Long Form |
: multiparametric prostate MRI |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
"In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation. |
DRE, HoLEP, iPCa, MRI-GB |
2 |
2020 |
Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation. |
bpMRI, bpMRI, DCE |
3 |
2020 |
Prostate MRI: staging and decision-making. |
--- |
4 |
2019 |
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization. |
GS |
5 |
2019 |
Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer. |
AUC, DWI, MRGB, T2WI, TZPC |
6 |
2019 |
Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men. |
ADC, CSPC, EEE, o-mpMRI criteria |
7 |
2018 |
Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications. |
--- |
8 |
2018 |
Multiparametric prostate MRI: technical conduct, standardized report and clinical use. |
PCa |
9 |
2018 |
[Estimating minimum period of time to perform prostate MRI after prostate biopsy: Clinical and histological bleeding risk factors; from a prospective study]. |
LUTS |
10 |
2017 |
Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa). |
ADC, GPS, PCa |
11 |
2017 |
Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. |
ADC, DCE, DWI, PI-RADSv2, T2W |
12 |
2016 |
Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2. |
DCE, DWI, PCa, PI-RADS |
13 |
2016 |
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. |
DCE, DW, GS, IRB, PCa, PI-RADSv2, PZ, T2WI, TZ |
14 |
2015 |
Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies. |
MR/TRUS, SQS |
15 |
2015 |
Implementation of Multi-parametric Prostate MRI in Clinical Practice. |
PI-RADS |
16 |
2015 |
Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients. |
AS, CTL, HPCI, MRI/TRUS, PCa, TV |
17 |
2014 |
An update on imaging techniques to optimize active surveillance in prostate cancer. |
AS |
18 |
2014 |
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. |
AUC, ESUR, PCa, PI-RADS, PSA |
19 |
2014 |
Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer. |
PCa, RP, SVI, SVs, US |
20 |
2014 |
Multiparametric MRI-targeted TRUS prostate biopsies using visual registration. |
csPCa, PCa, TB, TRUS-G |
21 |
2013 |
The state of prostate MRI in 2013. |
--- |
|